MannKind Corporation to Ring the Nasdaq Stock Market Opening Bell
Get Alerts MNKD Hot Sheet
Join SI Premium – FREE
WESTLAKE VILLAGE, Calif. and DANBURY, Conn., May 19, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will ring the opening bell at the Nasdaq stock exchange on Monday, May 23, 2022 at 9:30 am ET at the Nasdaq MarketSite at Times Square.
The ceremony will begin at approximately 9:15 am ET and can be viewed live from the Events & Presentations section of the Company’s website at https://investors.mannkindcorp.com/events-and-presentations.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company’s first FDA-approved product and the only inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. Afrezza is also available by prescription in Brazil, where it is commercialized by the Company’s partner, Biomm SA. MannKind was established in 1991, and is located in Danbury, Conn., and Westlake Village, Calif. The Company also employs field sales and medical representatives across the U.S. Please visit mannkindcorp.com to learn more.
MANNKIND CONTACTS:
Christie Iacangelo, Corporate Communications
(818) 292-3500
Email: [email protected]
Rose Alinaya, Investor Relations
(818) 661-5000
Email: [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Autodesk, Inc. with Losses to Contact the Firm
- Dork Lord Launches on Solana, Bringing Humor and Innovation to Crypto
- DiCello Levitt LLP Announces Investor Class Action Lawsuit Filed Against Lincoln National Corporation (NYSE: LNC) and Lead Plaintiff Deadline
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!